FDA approves Boehringer’s lung disease drug
(Reuters) – The U.S. Food and Drug Administration on Friday approved German drugmaker Boehringer Ingelheim’s Ofev capsules for a rare lung disorder. The drug is first FDA-approved treatment for this…
by October Gallery
(Reuters) – The U.S. Food and Drug Administration on Friday approved German drugmaker Boehringer Ingelheim’s Ofev capsules for a rare lung disorder. The drug is first FDA-approved treatment for this…